Arjun Mittra, MBBS

Arjun Mittra practices at OSU Internal Medicine in Columbus, Ohio.

Arjun Mittra's NPI, 1669730859, was assigned on April 25, 2012. Arjun Mittra holds Ohio license 35.139461.

Arjun Mittra's primary practice is OSU Internal Medicine, at 2050 Kenny Rd, Columbus, OH 43221 in Franklin County. The practice phone is (614) 293-2229.

Arjun Mittra's primary practice is OSU Internal Medicine in Columbus, Ohio. Arjun Mittra is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Arjun Mittra to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Arjun Mittra practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Arjun Mittra's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Arjun Mittra's licenses on file in 2 states: Ohio and Florida.

CMS data shows 265 Medicare services from Arjun Mittra across 5 procedure codes in 2024, for 126 Medicare patients. Medicare paid $25,757 for them.

CMS counts 126 Medicare patients who saw Arjun Mittra in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Arjun Mittra's median patient age at 68, with 43% women.

In 2024, Arjun Mittra wrote 150 Medicare Part D claims for 50 patients. 75% of them were for generic drugs. CMS names the drug for 54 of them, across 4 drugs with 11 or more claims each, at $10,179 in total drug cost. In 2023, CMS named 47 claims across 4 drugs.

Arjun Mittra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Arjun Mittra as offering telehealth.

Dmand AI links 23 papers to Arjun Mittra, published from 2011 to 2025. 2011 was the busiest year, with 4. The most frequent topics are Cell Line, Tumor, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Arjun Mittra has published most often in Cancers (Basel). Arjun Mittra's most frequent co-authors are Ashish Manne, MBBS, Alice Chen, DO and Pannaga G. Malalur, MD.

Dmand AI links Arjun Mittra to 1 clinical trial. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 8 general payments to Arjun Mittra from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Genentech, Inc. paid the most, $309.